Den europeiske union - engelsk - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - e. coli adhesin f4 (f4ab, f4ac, f4ad), e. coli adhesin f5, e. coli adhesin f6, e. coli adhesin f41 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - sows; sows (nullipar) - reduction of neonatal enterotoxicosis of piglets, caused by e. coli strains, expressing the adhesins f4ab, f4ac, f4ad, f5, f6 and f41, during the first days of life.

Den europeiske union - engelsk - EMA (European Medicines Agency)

ceva santé animale - inactivated fimbrial adhesins of escherichia coli f4ab, inactivated fimbrial adhesins of escherichia coli f4ac, inactivated fimbrial adhesins of escherichia coli f5, inactivated fimbrial adhesins of escherichia coli f6 - immunologicals for suidae - pigs - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6.

Den europeiske union - engelsk - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - pigs - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - escherichia coli k88ac pilus antigens; escherichia coli 987p pilus antigens; escherichia coli k99 pilus antigens; escherichia coli k88ab pilus antigens; formaldehyde solution; thiomersal - misc. vaccines or anti sera - escherichia coli k88ac pilus antigens vaccine-microbial active 12.5 ug/ml; escherichia coli 987p pilus antigens vaccine-microbial active 12.5 ug/ml; escherichia coli k99 pilus antigens vaccine-microbial active 12.5 ug/ml; escherichia coli k88ab pilus antigens vaccine-microbial active 12.5 ug/ml; formaldehyde solution aldehyde other 2.5 ug/ml; thiomersal mercury other 0.15 mg/ml - immunotherapy - pig - piglet | neonatal piglet | new born pig | sucker pig - escherichia coli (e. coli) | scours - neonatal | vaccine | equine rotavirus | including b-lactamase producin

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - erysipelothrix rhusiopathiae; whole cell e. coli including fimbrial antigens k88, k99; leptospira interrogans serovar pomona; formaldehyde; thiomersal - misc. vaccines or anti sera - erysipelothrix rhusiopathiae vaccine-general active 0.0 u; whole cell e. coli including fimbrial antigens k88, k99 vaccine-microbial active 0.0 u; leptospira interrogans serovar pomona vaccine-microbial active 0.0 u; formaldehyde aldehyde other 0.3 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pig - piglet | pigs | boar | gilt | neonatal piglet | new born pig | piglet | sow | sucker pig | swine - erysipelas infection | escherichia coli scours | leptospirosis - leptospira pomona | l. interrogans serovar pomona | leptospira pomona infection | white scours

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - whole cell e. coli including fimbrial antigens k88, k99; formaldehyde; thiomersal - parenteral liquid/solution/suspension - whole cell e. coli including fimbrial antigens k88, k99 vaccine-microbial active 0.0 p; formaldehyde aldehyde other 1.2 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pig - piglet | neonatal piglet | new born pig | sucker pig - escherichia coli (e. coli) | scours - neonatal | vaccine | equine rotavirus | including b-lactamase producin

Den europeiske union - svensk - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - e. coli adhesin f4 (f4ab, f4ac, f4ad), e. coli adhesin f5, e. coli adhesin f6, e. coli adhesin f41 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - sows; sows (nullipar) - reduktion av neonatal enterotoxicosis hos grisar, orsakad av e. coli-stammar, som uttrycker adhesinerna f4ab, f4ac, f4ad, f5, f6 och f41 under de första dagarna av livet.

Den europeiske union - dansk - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - e. coli adhesin f4 (f4ab, f4ac, f4ad), e. coli adhesin f5, e. coli adhesin f6, e. coli adhesin f41 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - sows; sows (nullipar) - reduktion af neonatal enterotoxicosis af smågrise, der er forårsaget af e. coli-stammer, der udtrykker adhesinerne f4ab, f4ac, f4ad, f5, f6 og f41, i de første dage af livet.

Den europeiske union - dansk - EMA (European Medicines Agency)

ceva santé animale - inactivated fimbrial adhesins of escherichia coli f4ab, inactivated fimbrial adhesins of escherichia coli f4ac, inactivated fimbrial adhesins of escherichia coli f5, inactivated fimbrial adhesins of escherichia coli f6 - immunologiske stoffer til suidae - svin - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6.

Den europeiske union - engelsk - EMA (European Medicines Agency)

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - pigs - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b.- to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.